Ex vivo evaluation of a novel through-the-scope traction device for endoscopic submucosal dissection
Endoscopy International Open · 17.06.2025 · 13 (CP)
DOI: 10.1055/a-2576-5837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 17.06.2025. Verfasst von Ludovico Alfarone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Unit, IRCCS Humanitas Research Hospital Department of Gastroenterology, Rozzano, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endoscopic submucosal dissection (ESD) is a technique used for resection of large neoplastic lesions, providing great oncological outcomes. However, ESD is technically challenging with a long learning curve, high complication rates, and extended procedure times. To address these limitations, various traction-assisted methods have been developed. This study evaluated a novel through-the-scope traction device (TRACMOTION, Fujifilm, Japan), which offers consistent and adjustable traction, in a pilot multicenter randomized ex vivo trial. The study included six endoscopists with limited ESD experience performing ESD on ex vivo porcine stomach models. Participants were randomized into two groups: those using TRACMOTION-assisted ESD (TM-ESD) and those performing conventional ESD (C-ESD). Each trainee completed six procedures, split equally between both groups. The primary outcome was resection speed, whereas secondary outcomes included en bloc, R0 resection rates, perforation rates, and rates of speedy procedures (>20 mm²/min). The TM-ESD group achieved a higher median resection speed of 20.75 mm²/min (95% confidence interval [CI] 14.56–29.25) in comparison to 15.10 mm²/min (95% CI 12.8–16.6) in the C-ESD group (P=0.02). Perforation rates were significantly lower in the TM-ESD group (11.1% (95% CI 0.01–0.34) vs. 61.1% (95% CI 0.35–0.82; P=0.0002). No significant differences were observed in en bloc or R0 resection rates between the groups. TRACMOTION significantly improves the efficiency of ESD, reducing procedure time and complication rates. This traction device could potentially facilitate broader adoption of ESD in clinical practice. However, further research in human trials is necessary to validate these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endoscopy Unit, IRCCS Humanitas Research Hospital Department of Gastroenterology, Rozzano, Italy.
- Gastroenterology, IBD Unit, Department of Clinical Medicine and Surgery, Università degli Studi di Napoli Federico II, Napoli, Italy.
- Gastroenterology and Endoscopy, Hôpital Européen Georges Pompidou, Paris, France.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
ORCID-Profile: Roberto De Sire, Cesare Hassan
Zitieren
APA
Alfarone, L., De Sire, R., Rosenbaum, B., Aidibi, A., Cellier, C., Hassan, C., Repici, A., Rahmi, G., & Maselli, R. (2025). Ex vivo evaluation of a novel through-the-scope traction device for endoscopic submucosal dissection. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2576-5837
Vancouver
Alfarone L, De Sire R, Rosenbaum B, Aidibi A, Cellier C, Hassan C, et al. Ex vivo evaluation of a novel through-the-scope traction device for endoscopic submucosal dissection. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2576-5837
BibTeX
@article{Alfarone2025,
author = {Alfarone, Ludovico and De Sire, Roberto and Rosenbaum, Boris and Aidibi, Ali and Cellier, Christophe and Hassan, Cesare and Repici, Alessandro and Rahmi, Gabriel and Maselli, Roberta},
title = {Ex vivo evaluation of a novel through-the-scope traction device for endoscopic submucosal dissection},
journal = {Endoscopy International Open},
year = {2025},
volume = {13},
number = {CP},
doi = {10.1055/a-2576-5837}
}
EUVIMED